BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1849181)

  • 1. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 3. Transmission of hepatitis C virus by health care workers in a rural area of Japan.
    Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Kawakami Y; Akazawa K; Kashiwagi S
    Am J Gastroenterol; 1995 May; 90(5):794-9. PubMed ID: 7537445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation of HBV and/or HCV carrier populations in Hiroshima prefecture and in Japan based on the date from voluntary blood donors].
    Tanaka J
    Nihon Koshu Eisei Zasshi; 1997 Oct; 44(10):788-96. PubMed ID: 9436387
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance and the problems of HCV antibody].
    Yano M
    Nihon Rinsho; 1991 Feb; 49(2):402-8. PubMed ID: 1849200
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-transfusion hepatitis C in Finland].
    Ebeling F
    Duodecim; 1993; 109(8):709. PubMed ID: 7520387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical investigation of HCV antibodies positive cases in the district with high mortality rate of liver diseases in Saga Prefecture].
    Hara T; Setoguchi Y; Yamamoto K; Ozaki I; Wada I; Fukusima N; Mizuta T; Kajihara S; Sakai T
    Fukuoka Igaku Zasshi; 1993 Feb; 84(2):54-7. PubMed ID: 8390393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sashima epidemic hepatitis: epidemiological feature and anti-HCV status].
    Wakayama Y; Aramaki T
    Nihon Rinsho; 1991 Feb; 49(2):397-401. PubMed ID: 1849199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
    Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
    Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology and infection route of asymptomatic HCV carriers detected through blood donations.
    Shimoyama R; Sekiguchi S; Suga M; Sakamoto S; Yachi A
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():1-5. PubMed ID: 7689501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-borne non-A, non-B hepatitis: hepatitis C.
    Genesca J; Esteban JI; Alter HJ
    Semin Liver Dis; 1991 May; 11(2):147-64. PubMed ID: 1653459
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 19. The declining risk of post-transfusion hepatitis C virus infection.
    Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
    N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The recent incidence of post-transfusion hepatitis C since the implementation of the anti-HCV screening program for blood donors].
    Katayama T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):383-8. PubMed ID: 7563764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.